Finance

Beta
Lists
6869:TYO
Sysmex Corp
Â¥1,528.50
+0.03%
(+0.50) 1D
Jul 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6869...
Open
Â¥1,564
High
Â¥1,582
Low
Â¥1,528
Mkt. cap
962.16B
Avg. vol.
5.16M
Volume
2.90M
Dividend
2.36%
Quarterly dividend
Â¥9
Ex-dividend date
Sep 29, 2025
P/E ratio
26.87
52-wk high
Â¥2,564
52-wk low
Â¥1,246
EPS
Â¥57
Shares outstanding
208.64M
No. of employees
11K
Open
Â¥1,564
High
Â¥1,582
Low
Â¥1,528
Mkt. cap
962.16B
Avg. vol.
5.16M
Volume
2.90M
Dividend
2.36%
Quarterly dividend
Â¥9
Ex-dividend date
Sep 29, 2025
P/E ratio
26.87
52-wk high
Â¥2,564
52-wk low
Â¥1,246
EPS
Â¥57
Shares outstanding
208.64M
No. of employees
11K
News stories
From sources across the web
Profile
Sysmex Corporation is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers. The company was renamed Sysmex Corporation in 1998 taking advantage of brand recognition of their machines. Wikipedia
About Sysmex Corp
CEOHisashi Ietsugu
Employees10.9K
FoundedFeb 20, 1968
HeadquartersKobe, Hyogo, Japan
SectorMedical device
Last report
May 14, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
138.84B / 139.00B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
105.73B
126.80B
128.64B
138.84B
Cost of goods sold
51.27B
58.70B
63.57B
70.79B
Cost of revenue
51.27B
58.70B
63.57B
70.79B
Research and development expenses
6.41B
6.80B
7.24B
-20.44B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.30B
39.58B
42.33B
73.31B
Operating expense
43.83B
45.76B
49.38B
53.20B
Total operating expenses
95.10B
104.47B
112.94B
123.99B
Operating income
10.63B
22.33B
15.70B
14.85B
Other non operating income
-3.00M
-1.00M
3.00M
-640.00M
EBT including unusual items
7.87B
22.08B
17.52B
1.58B
EBT excluding unusual items
7.87B
22.08B
17.52B
14.70B
Income tax expense
3.40B
7.70B
2.86B
-272.00M
Effective tax rate
43.14%
34.85%
16.30%
-17.22%
Other operating expenses
-869.00M
-609.00M
-199.00M
337.00M
Net income
4.55B
14.47B
14.68B
1.76B
Net profit margin
4.31%
11.41%
11.41%
1.27%
Earnings per share
-
-
-
-
Interest and investment income
198.00M
243.00M
270.00M
541.00M
Interest expense
-909.00M
-905.00M
-847.00M
-
Net interest expenses
-711.00M
-662.00M
-577.00M
541.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.39B
34.40B
27.69B
26.47B
Gain or loss from assets sale
57.00M
100.00M
463.00M
11.72B
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more